Financial News
Press Releases about Pfizer
![](https://www.newmediawire.com/media/sites/270/images/social-image.jpg)
![](https://www.newmediawire.com/media/sites/270/images/social-image.jpg)
![](https://www.prlog.org/13001943-swixx.png)
![](https://mms.businesswire.com/media/20240125523192/en/2009998/5/logo_Astellas_Horizontal_FullColor_CMYK.jpg)
![](https://www.marketbeat.com/logos/articles/med_20240124120518_5-top-healthcare-stocks-for-earnings-growth-in-202.jpg)
![](https://www.newmediawire.com/media/sites/270/images/social-image.jpg)
![](https://www.marketbeat.com/logos/articles/med_20240122102331_sarepta-therapeutics-inc.jpg)
![](https://www.newmediawire.com/media/sites/270/images/social-image.jpg)
![](https://www.newmediawire.com/media/sites/270/images/social-image.jpg)
Via NewMediaWire
Topics
Lawsuit
![](https://www.newmediawire.com/media/sites/270/images/social-image.jpg)
Via NewMediaWire
Topics
Lawsuit
![](https://www.newmediawire.com/media/sites/270/images/social-image.jpg)
![](https://www.marketbeat.com/logos/articles/med_20240116085908_unitedhealths-rising-premiums-could-cushion-stubbo.jpg)
DGE’s 3rd Real World Evidence & Market Access
January 11, 2024
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
![](https://www.marketbeat.com/logos/articles/med_20240110195346_astrazeneca-rebound-in-2024-with-double-digit-earn.jpg)
![](https://mms.businesswire.com/media/20240109145168/en/1045874/5/Pfizer_Logo_Color_RGB_APPROVED.jpg)
![](https://mms.businesswire.com/media/20240105049976/en/1989817/5/Genmab_Logo_Color_RGB.jpg)
![](https://mms.businesswire.com/media/20240109858951/en/1045874/5/Pfizer_Logo_Color_RGB_APPROVED.jpg)
![](https://mms.businesswire.com/media/20231221936013/en/1045874/5/Pfizer_Logo_Color_RGB_APPROVED.jpg)
Exciting New Cures Possible from GLP-1 Diabetes, Weight-Loss Drugs
January 08, 2024
![](https://www.marketbeat.com/logos/articles/med_20240108072132_2-low-priced-gene-therapy-stocks-to-speculate-on.jpg)
![](https://www.marketbeat.com/logos/articles/med_20240104091800_is-the-january-effect-reliable-indicator-for-yearl.jpg)
![](https://mms.businesswire.com/media/20240102942713/en/1045874/5/Pfizer_Logo_Color_RGB_APPROVED.jpg)
Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference
January 02, 2024
From Pfizer Inc.
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.